Literature DB >> 22318136

The human respiratory syncytial virus matrix protein is required for maturation of viral filaments.

Ruchira Mitra1, Pradyumna Baviskar, Rebecca R Duncan-Decocq, Darshna Patel, Antonius G P Oomens.   

Abstract

An experimental system was developed to generate infectious human respiratory syncytial virus (HRSV) lacking matrix (M) protein expression (M-null virus) from cDNA. The role of the M protein in virus assembly was then examined by infecting HEp-2 and Vero cells with the M-null virus and assessing the impact on infectious virus production and viral protein trafficking. In the absence of M, the production of infectious progeny was strongly impaired. Immunofluorescence (IF) microscopy analysis using antibodies against the nucleoprotein (N), attachment protein (G), and fusion protein (F) failed to detect the characteristic virus-induced cell surface filaments, which are believed to represent infectious virions. In addition, a large proportion of the N protein was detected in viral replication factories termed inclusion bodies (IBs). High-resolution analysis of the surface of M-null virus-infected cells by field emission scanning electron microscopy (SEM) revealed the presence of large areas with densely packed, uniformly short filaments. Although unusually short, these filaments were otherwise similar to those induced by an M-containing control virus, including the presence of the viral G and F proteins. The abundance of the short, stunted filaments in the absence of M indicates that M is not required for the initial stages of filament formation but plays an important role in the maturation or elongation of these structures. In addition, the absence of mature viral filaments and the simultaneous increase in the level of the N protein within IBs suggest that the M protein is involved in the transport of viral ribonucleoprotein (RNP) complexes from cytoplasmic IBs to sites of budding.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22318136      PMCID: PMC3318654          DOI: 10.1128/JVI.06744-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  59 in total

1.  A new Sendai virus vector deficient in the matrix gene does not form virus particles and shows extensive cell-to-cell spreading.

Authors:  Makoto Inoue; Yumiko Tokusumi; Hiroshi Ban; Takumi Kanaya; Masayuki Shirakura; Tsuyoshi Tokusumi; Takahiro Hirata; Yoshiyuki Nagai; Akihiro Iida; Mamoru Hasegawa
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

2.  Distribution of the attachment (G) glycoprotein and GM1 within the envelope of mature respiratory syncytial virus filaments revealed using field emission scanning electron microscopy.

Authors:  Chris E Jeffree; Helen W McL Rixon; Gaie Brown; James Aitken; Richard J Sugrue
Journal:  Virology       Date:  2003-02-15       Impact factor: 3.616

3.  Cooperativity of actin and microtubule elements during replication of respiratory syncytial virus.

Authors:  Nicole L Kallewaard; Amber L Bowen; James E Crowe
Journal:  Virology       Date:  2005-01-05       Impact factor: 3.616

4.  Association of respiratory syncytial virus M protein with viral nucleocapsids is mediated by the M2-1 protein.

Authors:  Dongsheng Li; David A Jans; Phillip G Bardin; Jayesh Meanger; John Mills; Reena Ghildyal
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

5.  Measles viruses with altered envelope protein cytoplasmic tails gain cell fusion competence.

Authors:  T Cathomen; H Y Naim; R Cattaneo
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

6.  Influence of lipids on the interfacial disposition of respiratory syncytical virus matrix protein.

Authors:  Helen K McPhee; Jennifer L Carlisle; Andrew Beeby; Victoria A Money; Scott M D Watson; R Paul Yeo; John M Sanderson
Journal:  Langmuir       Date:  2010-12-09       Impact factor: 3.882

7.  Morphogenesis and ultrastructure of respiratory syncytial virus.

Authors:  T Bächi; C Howe
Journal:  J Virol       Date:  1973-11       Impact factor: 5.103

8.  Sorting of the respiratory syncytial virus matrix protein into detergent-resistant structures is dependent on cell-surface expression of the glycoproteins.

Authors:  Gary Henderson; Jillian Murray; Robert P Yeo
Journal:  Virology       Date:  2002-09-01       Impact factor: 3.616

9.  Use of a novel cell-based fusion reporter assay to explore the host range of human respiratory syncytial virus F protein.

Authors:  Patrick J Branigan; Changbao Liu; Nicole D Day; Lester L Gutshall; Robert T Sarisky; Alfred M Del Vecchio
Journal:  Virol J       Date:  2005-07-13       Impact factor: 4.099

10.  Profilin is required for viral morphogenesis, syncytium formation, and cell-specific stress fiber induction by respiratory syncytial virus.

Authors:  Vira Bitko; Anja Oldenburg; Nicolle E Garmon; Sailen Barik
Journal:  BMC Microbiol       Date:  2003-05-09       Impact factor: 3.605

View more
  38 in total

1.  The respiratory syncytial virus fusion protein targets to the perimeter of inclusion bodies and facilitates filament formation by a cytoplasmic tail-dependent mechanism.

Authors:  Pradyumna S Baviskar; Anne L Hotard; Martin L Moore; Antonius G P Oomens
Journal:  J Virol       Date:  2013-07-31       Impact factor: 5.103

2.  The comparative genomics of human respiratory syncytial virus subgroups A and B: genetic variability and molecular evolutionary dynamics.

Authors:  Lydia Tan; Frank E J Coenjaerts; Lieselot Houspie; Marco C Viveen; Grada M van Bleek; Emmanuel J H J Wiertz; Darren P Martin; Philippe Lemey
Journal:  J Virol       Date:  2013-05-22       Impact factor: 5.103

3.  Structural analysis of respiratory syncytial virus reveals the position of M2-1 between the matrix protein and the ribonucleoprotein complex.

Authors:  Gabriella Kiss; Jens M Holl; Grant M Williams; Eric Alonas; Daryll Vanover; Aaron W Lifland; Manasa Gudheti; Ricardo C Guerrero-Ferreira; Vinod Nair; Hong Yi; Barney S Graham; Philip J Santangelo; Elizabeth R Wright
Journal:  J Virol       Date:  2014-04-23       Impact factor: 5.103

4.  Tetramerization of Phosphoprotein is Essential for Respiratory Syncytial Virus Budding while its N Terminal Region Mediates Direct Interactions with the Matrix Protein.

Authors:  Monika Bajorek; Marie Galloux; Charles-Adrien Richard; Or Szekely; Rina Rosenzweig; Christina Sizun; Jean-Francois Eleouet
Journal:  J Virol       Date:  2021-01-06       Impact factor: 5.103

5.  CX3CR1 is an important surface molecule for respiratory syncytial virus infection in human airway epithelial cells.

Authors:  Tatiana Chirkova; Songbai Lin; Antonius G P Oomens; Kelsey A Gaston; Seyhan Boyoglu-Barnum; Jia Meng; Christopher C Stobart; Calvin U Cotton; Tina V Hartert; Martin L Moore; Assem G Ziady; Larry J Anderson
Journal:  J Gen Virol       Date:  2015-06-25       Impact factor: 3.891

6.  Mutating the CX3C Motif in the G Protein Should Make a Live Respiratory Syncytial Virus Vaccine Safer and More Effective.

Authors:  S Boyoglu-Barnum; S O Todd; J Meng; T R Barnum; T Chirkova; L M Haynes; S J Jadhao; R A Tripp; A G Oomens; M L Moore; L J Anderson
Journal:  J Virol       Date:  2017-04-28       Impact factor: 5.103

Review 7.  Molecular mechanisms driving respiratory syncytial virus assembly.

Authors:  Fyza Y Shaikh; James E Crowe
Journal:  Future Microbiol       Date:  2013-01       Impact factor: 3.165

8.  Respiratory syncytial virus: virology, reverse genetics, and pathogenesis of disease.

Authors:  Peter L Collins; Rachel Fearns; Barney S Graham
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

9.  The Respiratory Syncytial Virus Phosphoprotein, Matrix Protein, and Fusion Protein Carboxy-Terminal Domain Drive Efficient Filamentous Virus-Like Particle Formation.

Authors:  Chetan D Meshram; Pradyumna S Baviskar; Cherie M Ognibene; Antonius G P Oomens
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

10.  Architecture of respiratory syncytial virus revealed by electron cryotomography.

Authors:  Lassi Liljeroos; Magdalena Anna Krzyzaniak; Ari Helenius; Sarah Jane Butcher
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.